Latest filing published 15 Jun 2026 for BRIGHT MINDS BIOSCIENCES INC..
No signal scores available.
All filings by Stephen Douglas Collins on record concern Bright Minds Biosciences Inc. Over a trading history stretching from 10 February 2025 to 25 May 2026, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 15 June 2026 with an option exercise in Bright Minds Biosciences Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations